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Introduction 
Bronchiectasis, which is a sequel to childhood infec- 
tion, is characterized by lung function decline akin to 
that in the general population (1,2). Bronchiectasis 
in cystic fibrosis is a consequence of altered mucus 
rheology, which predisposes the airway to mucoid 
impaction and recurrent lower respiratory infection. 
The pathology in cystic fibrosis is widespread and 
constantly active compared to bronchiectasis. This can 
cause a faster decline of lung function in cystic fibrosis. 
The goal of this report was to compare lung function 
decline in cystic fibrosis and bronchiectasis. 
Materials and Methods 
Twenty-eight cases of cystic fibrosis (Cystics), 
documented by raised sweat chloride and sodium, 
were studied. Age- and sex-matched patients with 
bilateral bronchiectasis and comparable lung functions 
(FEW, and FVC post-bronchodilator f 50 ml that of 
Cystics) were Controls. Spirometry was performed 6 h 
after bronchodilator medication, and approximately 
2 h after eating and chest physiotherapy, using the 
modified Steadwell’s water-sealed spirometer. Lung 
functions were repeated annually during stable state 
for 4 consecutive years. 
Subjects were treated conventionally (3), and admit- 
ted for any increase in sputum over stable state, fever, 
leucocytosis or radiological evidence of deterioration, 
which could not be managed on outpatient basis. 
Sputum was cultured for organisms and antibiotic 
sensitivity during each admission, and also twice every 
year. Subjects with proven fat maldigestion were 
treated with pancreatic supplement and vitamins. 
Lung function parameters used for analysis were 
FVC and FEV, expressed in absolute values (1). 
Regression coefficients for serial FVC and FEV, were 
derived for each subject. Comparison of initial and 
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Fig. I Serial lung function in patients with bronchiectasis 
and cystic fibrosis. (A)FVC, bronchiectasis; (A)FVC, cystic 
fibrosis; ( W)FEV,, bronchiectasis; ( q l)FEV,, cystic fibrosis. 
final lung function within groups, as well as compari- 
son of function and regression coefficients between 
groups, was done using the paired t-test (2). 
Results 
Each group comprised 20 male and eight female 
subjects. The mean age was 13 k4.2 years (range 7-21 
years). 
Mean baseline FVC for Controls and Cystics 
were 168Ok268.9 ml and 1677.9f271.0 ml (P=O.52). 
It was respectively 1622.7 k271.5 ml and 1622.4 & 
242.8 ml (P= 0.98) in the first year, 1637.4f 258.7 ml 
and 1609.9f271.3ml (P=O.O41) in the second, 
1606k 261.2ml and 1565.1f242.2ml (P=O.O05) in 
the third and 1585.9f257.7ml and 1551.3f261.2ml 
(P=O.O05) in the last year studied (Fig. 1). The 
mean annual decline in FVC was 23.9 ml and 31.6 ml, 
respectively. 
Mean baseline FEV, for Controls and Cystics 
were 1428.6k283.2 ml and 1456.8 f286.9 ml (P=O.2) 
respectively. The corresponding consecutive annual 
means were 1411.6k258.9 ml and 1412.1 k259.0 ml 
(P=O.98) in the first year, 1419.2k254.5 ml and 
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1376.8 + 266.3 ml (P= 0.052) in the second, 1407.9 f 
254.8ml and 1333.9+261.9ml (P=O.O009) in the 
third, and 1389.3 f 262.2 ml and 1323.9 + 253.3 ml 
(P=O.OOl) in the final year (Fig. 1). The mean annual 
decline in FEV, was 13.1 ml and 44.3 ml, respectively. 
FVC in both groups was significantly lower than 
baseline from the first year (mean fall 57.9ml and 
55.4 ml, respectively, for the first year). FEV, was more 
stable in Controls. It dipped significantly below base- 
line only by the fourth year (P=O.O13). In Cystics 
FEV, declined significantly within the first year. 
Regression coefficients for FVC and FEV, were 
lower in Cystics. One control subject had a positive 
coefficient for FVC compared to none from Cystics. 
Ten Controls as compared to one cystic had a positive 
coefficient for FEV,. Of the 28 controlled pairs, 
Cystics had a lower coefficients in 22 and 24 instances 
respectively for FVC and FEV,. 
Discussion 
In bronchiectasis as in chronic bronchitis the bulk of 
sputum is produced in the large airway, as only about 
10% of mucus glands are in the small airway. Since 
airway obstruction begins in the small airway, the 
pathology of bronchiectasis would contribute little to 
obstruction (4). This could explain why lung function 
is stable in Controls. 
A subgroup of bronchitis has been described with 
rapid decline in lung function. This is due either to 
secretion, mucus gland hypertrophy or smooth muscle 
hyperplasia in the small airway (4). The altered mucus 
in Cystics impacts the small airway easily. This can 
cause lung function declines in Cystics just like in the 
susceptible bronchitic population. In Controls the 
pathology is localized to the abnormal segment which 
takes little part in ventilation. The remaining lung is 
relatively normal. Hence lung function declines slowly 
as reported before (1). The universal abnormality of 
the exocrine gland in Cystics, compared to the patchy 
pathology in Controls, could add to the greater decline 
in cystic fibrosis. 
Since lung function declines despite optimal man- 
agement, the stress should be on prevention of bron- 
chiectasis among Cystics detected when the lungs are 
still normal. Lung transplantation seems to be the only 
long-term solution for cystic fibrosis with established 
bronchiectasis. 
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